Enfortumab vedotin plus pembrolizumab in previously untreated advanced urothelial cancer Journal Article


Authors: Hoimes, C. J.; Flaig, T. W.; Milowsky, M. I.; Friedlander, T. W.; Bilen, M. A.; Gupta, S.; Srinivas, S.; Merchan, J. R.; McKay, R. R.; Petrylak, D. P.; Sasse, C.; Moreno, B. H.; Yu, Y.; Carret, A. S.; Rosenberg, J. E.
Article Title: Enfortumab vedotin plus pembrolizumab in previously untreated advanced urothelial cancer
Journal Title: Journal of Clinical Oncology
Volume: 41
Issue: 1
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2023-01-01
Start Page: 22
End Page: 31
Language: English
DOI: 10.1200/jco.22.01643
PROVIDER: EBSCOhost
PROVIDER: cinahl
PUBMED: 36041086
PMCID: PMC10476837
DOI/URL:
Notes: MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PubMed and PDF -- MSK corresponding author is Jonathan Rosenberg -- Accession Number: 160929612 -- Entry Date: In Process -- Revision Date: 20221226 -- Publication Type: Article -- Journal Subset: Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 8309333. -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jonathan Eric Rosenberg
    510 Rosenberg